| Product Code: ETC9961273 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Breast Biopsy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Breast Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Breast Biopsy Market - Industry Life Cycle |
3.4 United States (US) Breast Biopsy Market - Porter's Five Forces |
3.5 United States (US) Breast Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Breast Biopsy Market Revenues & Volume Share, By Image Guided Technology, 2021 & 2031F |
3.7 United States (US) Breast Biopsy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Breast Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of breast cancer in the United States |
4.2.2 Technological advancements in breast biopsy procedures |
4.2.3 Growing awareness about early detection and screening for breast cancer |
4.3 Market Restraints |
4.3.1 High cost associated with breast biopsy procedures |
4.3.2 Stringent regulatory requirements and approval processes |
4.3.3 Limited accessibility to advanced breast biopsy technologies in certain regions |
5 United States (US) Breast Biopsy Market Trends |
6 United States (US) Breast Biopsy Market, By Types |
6.1 United States (US) Breast Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Breast Biopsy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Breast Biopsy Market Revenues & Volume, By Vacuum Assisted Biopsy, 2021- 2031F |
6.1.4 United States (US) Breast Biopsy Market Revenues & Volume, By Core Needle Biopsy, 2021- 2031F |
6.1.5 United States (US) Breast Biopsy Market Revenues & Volume, By Fine Needle Aspiration Biopsy, 2021- 2031F |
6.2 United States (US) Breast Biopsy Market, By Image Guided Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Breast Biopsy Market Revenues & Volume, By Mri Guided Breast Biopsy, 2021- 2031F |
6.2.3 United States (US) Breast Biopsy Market Revenues & Volume, By Ultrasound Guided Breast Biopsy, 2021- 2031F |
6.2.4 United States (US) Breast Biopsy Market Revenues & Volume, By Mammography Guided Stereotactic Biopsy, 2021- 2031F |
6.2.5 United States (US) Breast Biopsy Market Revenues & Volume, By Ct Guided Biopsy, 2021- 2031F |
6.2.6 United States (US) Breast Biopsy Market Revenues & Volume, By Other Image Guided Breast Biopsy, 2021- 2031F |
6.3 United States (US) Breast Biopsy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Breast Biopsy Market Revenues & Volume, By Hospitals And Clinics, 2021- 2031F |
6.3.3 United States (US) Breast Biopsy Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 United States (US) Breast Biopsy Market Import-Export Trade Statistics |
7.1 United States (US) Breast Biopsy Market Export to Major Countries |
7.2 United States (US) Breast Biopsy Market Imports from Major Countries |
8 United States (US) Breast Biopsy Market Key Performance Indicators |
8.1 Average waiting time for scheduling a breast biopsy procedure |
8.2 Number of facilities offering minimally invasive breast biopsy techniques |
8.3 Patient satisfaction rates with breast biopsy procedures |
8.4 Adoption rate of advanced imaging technologies in breast biopsy procedures |
8.5 Rate of false-negative results in breast biopsy tests |
9 United States (US) Breast Biopsy Market - Opportunity Assessment |
9.1 United States (US) Breast Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Breast Biopsy Market Opportunity Assessment, By Image Guided Technology, 2021 & 2031F |
9.3 United States (US) Breast Biopsy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Breast Biopsy Market - Competitive Landscape |
10.1 United States (US) Breast Biopsy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Breast Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here